CRIBADO: Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk Population

Sponsor
Hospital Universitario de Canarias (Other)
Overall Status
Completed
CT.gov ID
NCT01557101
Collaborator
(none)
200
2
2
14
100
7.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the adherence to screening in first grade relatives of patients with CCR is higher than optical colonoscopy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: COLON CAPSULE ENDOSCOPY ADHERENCE
  • Procedure: OPTICAL COLONOSCOPY ADHERENCE
Phase 4

Detailed Description

The purpose of this study is to compare the adherence and effectiveness of colon capsule endoscopy (CCE-2) versus conventional colonoscopy to screen first-degree relatives of patients with colorectal cancer.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Colon Capsule Endoscopy as Colorectal Cancer Method of Screening in The Familiar-Risk Population
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Apr 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: COLON CAPSULE ENDOSCOPY

Procedure: COLON CAPSULE ENDOSCOPY ADHERENCE
An exploration with a COLON CAPSULE ENDOSCOPY eaten which capsule has a video-camera in both end to see the colon.

Other: OPTICAL COLONOSCOPY

Procedure: OPTICAL COLONOSCOPY ADHERENCE
An exploration with an OPTICAL COLONOSCOPY from the anus to see the colon.

Outcome Measures

Primary Outcome Measures

  1. Participation to colorectal cancer screening in first-degree relatives of patients with colorectal cancer [6 month follow up]

    Assess whether colon capsule endoscopy increases participation to colorectal cancer screening in first-degree relatives of patients with colorectal cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Asymptomatic first-degree relatives (parents, siblings or children) of CRC patients aged less than 60 years or with two or more first-degree relatives of any age.

  • Signing of informed consent.

Exclusion Criteria:
  • Personal history of adenoma or CRC.

  • History of hereditary CRC.

  • Chronic inflammatory disease.

  • Presence of digestive symptoms.

  • Patients with swallowing problems (dysphagia).

  • Personal history of gastrointestinal surgery.

  • Enteritis radioactive.

  • Renal failure.

  • Congestive heart failure

  • Allergy or other contraindication to Bysacodyl to PEG or phosphates.

  • Pregnancy.

  • Suspected bowel obstruction or intestinal strictures or fistulas known.

  • Colectomy.

  • Paralysis with impaired intestinal motility.

  • Any other process that the investigator's discretion to make inadequate participation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Digestive Service, Huc La Laguna S/c de Tenerife Spain 38320
2 Hospital Universitario de Canarias La Laguna S/c de Tenerife Spain 38320

Sponsors and Collaborators

  • Hospital Universitario de Canarias

Investigators

  • Principal Investigator: Enrique Quintero, MD. PhD., Hospital Universitario de Canarias

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Universitario de Canarias
ClinicalTrials.gov Identifier:
NCT01557101
Other Study ID Numbers:
  • CEC_cribado_CCR
First Posted:
Mar 19, 2012
Last Update Posted:
Jan 9, 2014
Last Verified:
Jan 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 9, 2014